{"id":2645,"date":"2019-10-30T18:12:38","date_gmt":"2019-10-30T22:12:38","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/reuters-quotes-hunter-shkolnik-on-teva-pharmaceuticals\/"},"modified":"2022-06-27T02:34:22","modified_gmt":"2022-06-27T06:34:22","slug":"reuters-quotes-hunter-shkolnik-on-teva-pharmaceuticals","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/de\/weise-papiere\/reuters-quotes-hunter-shkolnik-on-teva-pharmaceuticals\/","title":{"rendered":"Reuters zitiert Hunter Shkolnik zu Teva Pharmaceuticals"},"content":{"rendered":"<p>In interviews with Reuters, lawyers representing local governments in the opioid litigation said the figure proposed by Teva inflates the real value of the drugs. They said the proposal will not be enough to address a nationwide addiction crisis that has claimed some 400,000 lives over the last two decades.<\/p>\n<p>The deal is \u201covervalued to make the settlement look better,\u201d said Hunter Shkolnik, a lawyer on the plaintiffs executive committee that is managing more than 2,300<br \/>\nfederal lawsuits consolidated in the U.S. District Court in Cleveland. \u201cI don\u2019t believe a no-cash payment from Teva, one of the largest generic manufacturers in the world, is appropriate,\u201d he told Reuters.<\/p>\n<p>Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson &amp; Johnson and the three largest U.S. drug distributors, AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp.<\/p>","protected":false},"excerpt":{"rendered":"<p>In Interviews mit Reuters sagten Anw\u00e4lte, die lokale Regierungen in dem Opioid-Rechtsstreit vertreten, dass die von Teva vorgeschlagene Zahl den tats\u00e4chlichen Wert der Drogen \u00fcberh\u00f6ht. Sie sagten, der Vorschlag werde\u2026<\/p>","protected":false},"featured_media":0,"menu_order":238,"template":"","whitepaper_category":[57,75,98,253,254],"whitepaper-source":[277],"class_list":["post-2645","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-hunter-shkolnik","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-reuters"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers\/2645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers\/2645\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/media?parent=2645"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepaper_category?post=2645"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepaper-source?post=2645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}